(Q35580458)

9 August 2017

1 reference

title

Emtricitabine: an antiretroviral agent for HIV infection (English)

1 reference

9 August 2017

1 reference

ChEBI release 2020-05-28

2

Lesley J Scott

1 reference

9 August 2017

Lynne M Bang

1

1 reference

9 August 2017

publication date

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

63

1 reference

9 August 2017

issue

22

1 reference

9 August 2017

page(s)

2413-24; discussion 2425-6

1 reference

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides

9 August 2017

cites work

1 reference

12 December 2020

Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity

1 reference

12 December 2020

Human immunodeficiency viruses and drug therapy: resistance and implications for antiretroviral therapy

1 reference

12 December 2020

Relative anti-HIV-1 efficacy of lamivudine and emtricitabine in vitro is dependent on cell type

1 reference

12 December 2020

Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus

1 reference

12 December 2020

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

1 reference

12 December 2020

Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

1 reference

12 December 2020

Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus

1 reference

12 December 2020

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

1 reference

12 December 2020

Assessment of the relative potency of emtricitabine and lamivudine

1 reference

12 December 2020

Reproductive toxicology profile of emtricitabine in mice and rabbits

1 reference

12 December 2020

Prototype trial design for rapid dose selection of antiretroviral drugs: an example using emtricitabine (Coviracil).

1 reference

12 December 2020

Mechanistic studies show that (-)-FTC-TP is a better inhibitor of HIV-1 reverse transcriptase than 3TC-TP

1 reference

12 December 2020

Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase

1 reference

12 December 2020

10.2165/00003495-200363220-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1007009472

0 references

1 reference